Concepedia
Statistics
Publications
8
Citations
514
H-Index
Active since
2012
Affiliations
University of Oxford(Current)
Ludwig Cancer Research
CRUK/MRC Oxford Institute for Radiation Oncology
Martin Luther University Halle-Wittenberg
Leiden University Medical Center
Anna M. Grawenda is an author at University of Oxford specializing in molecular oncology, oncology, and medicine.
Publications per year
2012–2021
TGF-β Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear Translocation
Dafni‐Eleftheria Pefani, Daniela Paňková, Aswin Abraham et al. · Molecular Cell · 2016 · 143 citations · Full text
Life Sciences, Molecular Biology, Molecular Genetics +14
RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73
Angelos Papaspyropoulos, Leanne Bradley, Asmita Thapa et al. · Nature Communications · 2018 · 102 citations · Full text
Life Sciences, Cell Biology, Developmental Biology +17
Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion
Nikola Vlahov, Simon Scrace, Manuel Sarmiento Soto et al. · Current Biology · 2015 · 81 citations · Full text
Medicine, Cancer Biology, Oncology +17
Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
Kristiaan Lenos, Anna M. Grawenda, Kirsten Lodder et al. · Cancer Research · 2012 · 64 citations · Full text
Medicine, Molecular Biology, Oncology +16
A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma
Karen S. Yee, Lukasz F. Grochola, Garth Hamilton et al. · Cancer Research · 2012 · 47 citations · Full text
Life Sciences, Genetics, Oncology +17
1–5 of 8